prostate biopsy

Related by string. Prostate Biopsy * prostates . Prostate . Prostates . PROSTATE : Prostate Specific Antigen PSA . prostate specific antigen . Prostate Cancer Charity . metastatic prostate cancer . localized prostate cancer / Biopsy . biopsying : sentinel node biopsy . biopsy specimens . sentinel lymph node biopsy . lymph node biopsy * underwent prostate biopsy . undergo prostate biopsy *

Related by context. All words. (Click for frequent words.) 72 biopsy 71 biopsies 71 prostate biopsies 69 surgical biopsy 67 digital rectal examination 66 axillary dissection 66 sentinel node biopsy 66 SLNB 66 needle biopsy 66 transrectal ultrasound guided 65 EUS FNA 65 lymphadenectomy 65 sentinel nodes 65 breast biopsies 65 fine needle aspiration 65 liver biopsy 65 excisional biopsy 64 surgical biopsies 64 biochemical recurrence 64 PSA velocity 64 pelvic ultrasound 64 screening colonoscopy 64 coronary angiography 64 prostatectomy 64 serum PSA 64 clinically localized prostate 64 core needle biopsy 64 pelvic lymphadenectomy 64 needle biopsies 64 radical prostatectomy 64 coronary arteriography 63 sentinel lymph node biopsy 63 sentinel node 63 PCa 63 radical cystectomy 63 sentinel lymph node 63 digital rectal exams 63 specific antigen PSA 63 abnormal mammogram 62 benign lesions 62 screening mammogram 62 micrometastases 62 advanced adenomas 62 malignant lesions 62 catheter angiography 62 urine cytology 62 abnormal Pap test 62 lymph node dissection 62 EBUS FNA 62 invasive coronary angiography 62 CT angiogram 62 adjuvant chemotherapy 62 transurethral resection 62 endometrial carcinoma 62 coronary CTA 62 radical nephrectomy 62 mediastinoscopy 61 adenomatous polyps 61 cystectomy 61 colposcopy 61 axillary nodes 61 endometrial biopsy 61 SLN biopsy 61 upper endoscopy 61 CIN2 + 61 advanced neoplasia 61 colonoscopy 61 orchiectomy 61 invasive diagnostic 61 conventional angiography 61 Prostate Specific Antigen PSA 61 D dimer 61 hepatectomy 61 PSA screening 61 PSA nadir 61 operable breast cancer 61 BRCA mutation 61 undergo prostate biopsy 61 ASCUS 60 axillary lymph nodes 60 #.#ng/ml 60 neoadjuvant chemotherapy 60 axillary node dissection 60 undergone radical prostatectomy 60 adrenalectomy 60 optical colonoscopy 60 computed tomography scans 60 axillary lymph node 60 colectomy 60 adjuvant radiotherapy 60 abdominal hysterectomy 60 tumor recurrence 60 Amniocentesis 60 preoperative chemotherapy 60 adjuvant radiation 60 prostate cancer CaP 60 postoperative chemotherapy 60 atypia 60 FDG-PET/CT 60 mammographic density 60 endosonography 60 Biopsies 60 undergoing radical prostatectomy 60 chlamydial infection 60 lymph node involvement 60 CT coronary angiography 60 thyroid nodules 60 radical prostatectomy RP 60 prophylactic mastectomy 60 prostate specific 60 carotid stenosis 60 esophagectomy 59 KRAS mutation 59 cystoscopy 59 flexible sigmoidoscopy 59 abnormal mammograms 59 adenoma 59 R0 resection 59 ICD implantation 59 screening mammography 59 colonography 59 debulking surgery 59 salpingo oophorectomy 59 cytoreductive surgery 59 PSADT 59 FDG PET 59 BRCA mutations 59 lymph node removal 59 polyp detection 59 liver resection 59 EBRT 59 chest radiographs 59 advanced adenoma 59 liver biopsies 59 thyroglobulin 59 elective PCI 59 micrometastasis 59 helical CT 59 hepatic resection 59 sentinel lymph nodes 59 EBUS 59 F FDG PET 59 specific antigen 59 surgical excision 58 CaP 58 neoadjuvant therapy 58 hematuria 58 transesophageal echocardiography 58 radical retropubic prostatectomy 58 vaginal hysterectomy 58 DXA scan 58 core needle biopsies 58 perioperative mortality 58 prostate specific antigen 58 carotid endarterectomy 58 pT3 58 CIN3 58 underwent radical prostatectomy 58 BSGI 58 CT angiography 58 elevated CRP 58 digital rectal exam 58 postoperative mortality 58 prophylactic mastectomies 58 breast lesions 58 postoperative infection 58 ALND 58 renal biopsy 58 cholecystectomy 58 plain radiographs 58 nodal metastases 58 asymptomatic carotid stenosis 58 coronary artery calcium 58 pretest probability 58 incisional biopsy 58 TRUS biopsy 58 occult metastases 58 thyroidectomy 58 renal tumors 58 biopsied 58 Radical prostatectomy 58 angiography 58 TRUS 58 arteriography 58 postoperative complication 58 BRCA2 mutation carriers 58 atypical hyperplasia 58 chemoradiotherapy 58 curative resection 58 external beam radiotherapy 58 Recurrence Score 58 nephrectomy 58 CIN3 + 58 lymph node biopsy 58 axillary node 57 radioiodine therapy 57 HCV antibody 57 distant metastases 57 GnRH agonists 57 RALP 57 preoperative 57 sigmoidoscopy 57 VATS lobectomy 57 pCR 57 chemoradiation 57 lung nodules 57 transrectal 57 Ultrasonography 57 endoscopic resection 57 HGPIN 57 Biopsy 57 Prostate Specific Antigen 57 neoadjuvant 57 duplex ultrasonography 57 tissue biopsies 57 total thyroidectomy 57 inguinal hernia repair 57 lymph node metastases 57 preventive mastectomies 57 Subgroup analyzes 57 coronary CT angiography 57 unnecessary biopsies 57 tumor resection 57 axillary lymph node dissection 57 varicoceles 57 sonographic examinations 57 epithelial ovarian cancer 57 SUVmax 57 neoplasia 57 bronchoscopies 57 differentiated thyroid 57 TURBT 57 fecal occult blood 57 contralateral breast 57 oophorectomy 57 coronary angiogram 57 cervical carcinoma 57 pneumonectomy 57 Mohs surgery 57 abnormal Pap 57 PSA prostate 57 polypectomy 57 parathyroidectomy 57 prostates removed 57 contralateral prophylactic mastectomy 57 BRCA testing 57 spiral computed tomography 57 antigen PSA 56 bone marrow aspiration 56 bilateral oophorectomy 56 preventive mastectomy 56 diagnostic workup 56 conventional colonoscopy 56 TURP 56 screening colonoscopies 56 postoperative morbidity 56 warfarin therapy 56 resected 56 breast MRI 56 lipid lowering therapy 56 conventional coronary angiography 56 coronary revascularization 56 partial nephrectomy 56 recurrent VTE 56 laparotomy 56 adjuvant therapy 56 Computed tomography 56 lung biopsy 56 localized prostate cancer 56 needle aspiration 56 adjuvant hormonal therapy 56 transthoracic 56 malignant polyps 56 MSCT 56 transabdominal 56 preoperative staging 56 PET CT scans 56 DEXA scans 56 intravenous bisphosphonates 56 cervical lesions 56 endoscopists 56 locoregional recurrence 56 chest x ray 56 OPCAB 56 angiographically 56 PAP smear 56 echocardiographic 56 contralateral breast cancer 56 Magnetic resonance 56 breast MRIs 56 abnormal cytology 56 polyp removal 56 androgen deprivation 56 peritoneal cancer 56 NSTE ACS 56 CT colonography CTC 56 nodal dissection 56 prostatic adenocarcinoma 56 biopsied tissue 56 nonmetastatic prostate cancer 56 bone marrow biopsy 56 perioperative morbidity 56 microalbumin test 56 ovarian malignancy 56 heart catheterization 56 invasive biopsies 56 pre cancerous polyps 56 #F FDG PET 56 androgen suppression 56 female endoscopist 56 laparoscopic radical prostatectomy 56 invasive biopsy 56 BRCA mutation carriers 56 gadolinium enhanced 55 HSCT 55 benign breast 55 microalbuminuria 55 thrombophilia 55 malignant growths 55 malignant lesion 55 colonoscopic 55 mammographic screening 55 clinically insignificant 55 preoperative evaluation 55 urine dipstick 55 gastrectomy 55 needless biopsies 55 preoperative MRI 55 neoadjuvant treatment 55 postprocedure 55 underwent resection 55 pelvic lymph node dissection 55 hip resurfacing arthroplasty 55 nerve sparing 55 conventional cytology 55 oncologic outcomes 55 cTnI 55 atypical ductal hyperplasia 55 intravesical therapy 55 ERCP 55 cystoscopic 55 cytologic 55 PLCO 55 locoregional 55 tamoxifen therapy 55 lymph node metastasis 55 robotic prostatectomy 55 pump CABG 55 thoracoscopic lobectomy 55 wedge resection 55 B7 H3 55 HER2 expression 55 VCUG 55 biochemical relapse 55 renal cell carcinomas 55 radiation therapy 55 undetectable PSA 55 adnexal mass 55 seminal vesicle invasion 55 DXA 55 malignant nodules 55 colorectal neoplasia 55 cytoreduction 55 nephron sparing surgery 55 bisphosphonate therapy 55 androgen deprivation therapy 55 pancreatic resection 55 BRCA1 mutations 55 pT2 55 cardiac computed tomography 55 chorionic villus sampling 55 serum prostate 55 mammographic 55 premalignant lesions 55 transvaginal sonography 55 beta blocker therapy 55 sonographically guided 55 node dissection 55 FOBT 55 mammogram 55 sensitivity specificity 55 Hurthle cell 55 adenoma recurrence 55 chemoembolization 55 stenoses 55 biopsy specimens 55 arthrography 55 invasive carcinoma 55 SPECT MPI 55 androgen ablation 55 DEXA scan 55 adnexal masses 55 precancer 55 test FOBT 55 Sentinel Lymph Node Biopsy 55 TKAs 55 malignant lymph nodes 55 invasive angiography 55 preoperative PSA 55 transvaginal ultrasound 55 recanalization 55 prostate cancer PCa 55 NAbs 55 bilateral orchiectomy 55 screening mammograms 55 virologic failure 55 urinary cytology 55 tuberculin skin testing 55 chest radiography 55 adenotonsillectomy 55 postoperative radiotherapy 55 mCi 55 endoscopic examinations 54 postoperative complications 54 microscopic hematuria 54 histopathologic examination 54 preoperatively 54 intraperitoneal chemotherapy 54 PCA3 54 underwent surgical resection 54 T1 weighted images 54 laparoscopic cholecystectomy 54 endarterectomy 54 pelvic lymph nodes 54 anti JCV antibodies 54 nomogram 54 Cervista HPV HR 54 bowel resection 54 ultrasonography 54 dose ionizing radiation 54 AVODART 54 guaiac 54 LV dysfunction 54 grade dysplasia 54 electrocardiography 54 endoscopic ultrasound 54 immunohistochemical analysis 54 trabeculectomy 54 FDG uptake 54 Getzenberg 54 tonsil tissue 54 radical hysterectomy 54 asymptomatic 54 Breast MRIs 54 diagnostic angiography 54 amnio 54 NATRECOR ® 54 mammographically 54 intestinal metaplasia 54 Recurrences 54 angiogram 54 reoperations 54 esophagogastroduodenoscopy 54 anticoagulation therapy 54 definite stent thrombosis 54 precursor lesions 54 cerebral microbleeds 54 benign nodules 54 extracapsular extension 54 cervical biopsies 54 total knee arthroplasty 54 resections 54 flurpiridaz F 54 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 54 scintigraphic 54 parathyroid 54 prostate TURP 54 extracolonic findings 54 mediastinal lymph nodes 54 varicocele 54 recurrent prostate cancer 54 mitral valve replacement 54 coronary calcium 54 antibiotic prophylaxis 54 intravascular ultrasonography 54 total abdominal hysterectomy 54 intraoperatively 54 coronary artery stenosis 54 lobular carcinoma 54 randomizing patients 54 electron beam computed tomography 54 colonoscopy flexible sigmoidoscopy 54 PCA3 scores 54 latent tuberculosis infection 54 undetectable HBV DNA 54 cranial radiation 54 fibroadenomas 54 immunohistochemical 54 transrectal ultrasound 54 chemoradiation therapy 54 noncardiac surgery 54 cytoreductive nephrectomy 54 D Dimer 54 amniocentesis 54 brain perfusion scans 54 PCIs 54 PET scan 54 underwent coronary angiography 54 lymph node biopsies 54 computed tomography CT scan 54 diagnostic laparoscopy 54 antigen PSA levels 54 histopathologic 54 breast carcinoma 54 ultrasonographic 54 serum testosterone levels 54 glomerular filtration 54 endometrial hyperplasia 54 FDG PET imaging 54 paracentesis 54 precancerous polyp 54 EBCT 54 cytological 54 ovarian stimulation 54 liver transplant recipients 54 abnormal Pap smears 54 preoperative diagnosis 54 immunohistochemical staining 54 endoscopist 54 abdominal ultrasound 54 revascularization procedure 54 thyroid stimulating hormone 54 CT angiograms 54 BRCA2 mutation 54 stent implantation 54 nonmelanoma skin cancers 54 sonographic examination 54 para aortic 54 lumpectomy 54 LTBI 54 pharmacologic stress 54 Cystectomy 54 grade cervical intraepithelial 54 lung resection 54 Subgroup analysis 54 precancerous condition 54 preventative mastectomy 54 CT colonography 54 breast conserving 54 breast carcinomas 54 intact parathyroid hormone 53 allogeneic transplant 53 NMP# 53 tuberculin skin test 53 troponins 53 virtual colonography 53 pathologic examination 53 CABG surgeries 53 cerebral angiography 53 periprosthetic infection 53 denervation 53 QTc interval 53 invasive procedure 53 fibroadenoma 53 abnormal pap smear 53 coronary calcification 53 benign polyps 53 eGFR 53 endometrial cancers 53 fluoroscopy guided 53 cancerous polyps 53 revascularization procedures 53 stent placement 53 sustained virological response 53 postoperative infections 53 perioperative complications 53 stratifying patients 53 PAP smears 53 androgen deficiency 53 FDG PET CT 53 Angiographic 53 PROLARIS 53 resectable 53 stent stenosis 53 liver metastases 53 renal artery stenosis 53 KRAS mutations 53 aromatase inhibitor therapy 53 oropharyngeal cancer 53 axilla 53 osteoporotic fracture 53 pigmented skin lesions 53 HoLEP 53 Pap smear 53 gene amplification 53 bypass grafting 53 lymphovascular invasion 53 angiograms 53 radiotherapy RT 53 colorectal adenoma 53 myocardial revascularization 53 hysterectomy 53 MitraClip device 53 retroperitoneal 53 elastography 53 decompressive surgery 53 Radio Frequency Ablation 53 scintigraphy 53 coronary angiograms 53 node metastases 53 Flexi Scope 53 prostatectomies 53 venography 53 Doppler ultrasound 53 metastatic lesions 53 intima media thickness 53 non squamous NSCLC 53 renal transplantation 53 baseline mammogram 53 donor nephrectomy 53 partial mastectomy 53 pulmonary angiography 53 transurethral 53 acute aortic dissection 53 angioplasty procedures 53 myocardial viability 53 patients undergoing CABG 53 leiomyomas 53 prostate carcinoma 53 PSA kinetics 53 thoracotomy 53 BRCA2 mutations 53 dutasteride 53 multivessel disease 53 periprocedural 53 cTnT levels 53 undergo lumpectomy 53 hysterectomies performed 53 Postoperative complications 53 vertebral fracture 53 Kruskal Wallis test 53 seminomas 53 estimated glomerular filtration 53 angiography CTA 53 FDG PET scans 53 Oncotype DX Recurrence Score 53 β blockers 53 IgA deficiency 53 metachronous 53 serum testosterone 53 lung nodule 53 Doppler sonography 53 multidetector CT 53 perimenopausal women 53 histological examination 53 univariate analyzes 53 metastatic prostate cancer 53 SpHb 53 hemodilution 53 Framingham Risk Score 53 peritoneal carcinomatosis 53 concomitant antibiotics 53 logistic regression model 53 cTnT 53 CT Colonography 53 CIN2 53 laparoscopic hysterectomy 53 MGUS 53 hs CRP 53 histologically confirmed 53 MRgFUS 53 colorectal neoplasms 53 logistic regression analysis 53 magnetic resonance angiography 53 intraobserver 53 ovulation induction 53 HBsAg 53 Lymph node 53 colorectal polyp 53 epithelial tumors 53 BRAF V#E mutation 52 carotid revascularization 52 antimicrobial prophylaxis 52 LVNC 52 abnormal Pap smear 52 postintervention 52 ICD therapy 52 revascularization 52 submucosal 52 histological subtype 52 QTc prolongation 52 Bone density 52 ductal carcinomas 52 electrocardiography ECG 52 immunochemical 52 NMIBC 52 median sternotomy 52 computed tomography scan 52 pre malignant lesions 52 antibody titer 52 microcalcifications 52 guided percutaneous 52 adenoma detection 52 mediastinal 52 prostate tissue 52 histologically proven 52 hydroxyvitamin D levels 52 Sentinel node biopsy 52 nodal metastasis 52 colorectal polyps 52 calculated creatinine clearance 52 invasive breast cancer 52 hip BMD 52 coronary stenosis 52 histologic diagnosis 52 creatinine levels 52 multidetector row 52 histopathologic diagnosis 52 BMD measurements 52 cesarean delivery 52 ultrasound elastography 52 subgroup analyzes 52 d dimer 52 reperfusion therapy 52 mycophenolate mofetil 52 troponin 52 post operatively 52 cT3 prostate cancer 52 barium enemas 52 coronary intervention 52 eptifibatide 52 transrectal ultrasonography 52 intestinal biopsy 52 stenting procedures 52 barium enema 52 angiography CCTA 52 HNSCC 52 HIV HCV coinfected 52 subclinical atherosclerosis 52 MRI scans 52 RARP 52 Prostate Lung Colorectal 52 colposcopic 52 adjuvant therapies 52 thromboprophylaxis 52 undergo radical prostatectomy 52 bronchial thermoplasty 52 BRCA2 gene mutation 52 endophthalmitis 52 ELISpot 52 endometrial 52 percutaneous biopsy 52 atherothrombotic disease 52 urothelial carcinoma 52 distant metastasis 52 OGTT 52 androgen suppression therapy 52 invasive procedures 52 aneuploidy screening 52 undergone hysterectomy 52 undergo colonoscopy 52 angioplasty stenting 52 X ray angiography 52 FOLFOX4 52 SYNTAX trial 52 DEXA 52 nonobstructive CAD 52 coronary computed tomography 52 neoplasias 52 transcranial Doppler 52 multivariate logistic regression 52 breast lumps 52 BRAF mutation 52 genotypic resistance 52 transvaginal 52 prostate cancer CRPC 52 neoplasia PIN 52 platelet reactivity 52 abdominal computed tomography 52 cervical precancer 52 PCPT 52 NGAL 52 artery blockages 52 Immunohistochemistry 52 RVOT 52 HIPEC 52 procalcitonin 52 radiochemotherapy 52 CMV infection 52 metastatic RCC 52 abnormal Pap tests 52 TACE 52 microdissection 52 Kaplan Meier analysis 52 penetrating keratoplasty 52 ADPKD 52 tuberculin test 52 MRI exams 52 PET CT scan 52 Accelerated Partial Breast Irradiation 52 Logistic regression 52 Screening Trial 52 intravitreal injections 52 Prostate specific antigen 52 mitomycin C 52 pathologic fractures 52 fundoplication 52 perfusion abnormalities 52 DCIS lesions 52 perfusion imaging 52 ICDs implanted 52 coronary catheterization 52 malignancy 52 serologic testing 52 microalbumin 52 beam radiotherapy 52 endoscopic retrograde 52 MR imaging 52 metastatic malignant melanoma 52 defibrillator implant 52 gauge vitrectomy 52 univariate analysis 52 workup 52 thromboembolism 52 multislice 52 dual antiplatelet therapy 52 bilateral mastectomy 52 testosterone supplementation 52 retrospectively analyzed 52 lung resections 52 antithrombotic therapy 52 cytology 52 HNPCC 52 reimplantation 52 subclinical hyperthyroidism 52 Neoadjuvant 52 extracolonic 52 undergo mastectomy 52 adenoidectomy 52 carotid IMT 52 abdominal ultrasounds 52 nomograms 52 Coronary Artery Bypass Graft 52 laparoscopic colectomy 52 premalignant lesion 52 IV bisphosphonates 52 squamous intraepithelial lesions 52 colorectal liver metastases 52 underwent CABG 52 breast biopsy 52 bone scintigraphy 52 subtrochanteric 52 cardiac troponin 52 logistic regression models 52 melanoma lesions 52 sustained virologic response 52 MGd 52 cervical lymph nodes 52 Adenomas 52 ImmuKnow 52 bivariate analysis 52 intestinal polyps 52 Lp PLA2 52 postoperative atrial fibrillation 52 pelvic examinations 52 BRCA1 mutation carriers 52 lumbar discectomy 52 benign proliferative breast 52 taxane therapy 52 SpyGlass System 52 transthoracic echocardiography 52 mammographies 52 prostate adenocarcinoma 52 carotid plaque 52 laparoscopically assisted 52 colonoscopy screenings 52 randomized controlled trials RCTs 52 hamartomas 52 Breast Specific 52 conventional Pap smear 52 keratoplasty 52 trastuzumab Herceptin ® 52 myomectomy 52 electrocardiogram EKG 52 lymphatic mapping 52 invasive lobular carcinoma 52 prenatal diagnosis 52 APTIMA HPV 52 urolithiasis 52 noncardiac 52 lobectomy 52 #F FDG 52 serological tests 52 chromosomal mutations 52 ablations 52 Metastatic Prostate Cancer 52 gallstone disease 52 ablation procedures 52 sonographic findings 52 spiral CT scan 52 sonographically 52 gastric adenocarcinoma 52 lymph nodes 52 CT scans 52 PD2i R 52 carcinoid tumor 52 gonococcal infections 52 urinary symptoms 51 undergoing coronary angiography 51 mutated K ras 51 polyp recurrence 51 prognostically 51 thrombolytic therapy 51 resection 51 recurrent NSCLC 51 electrocardiographic 51 prior nephrectomy 51 laproscopic procedure 51 positron emission tomography scan 51 acetabular fractures 51 radical prostatectomies 51 clinico pathological 51 Breast Specific Gamma 51 intraoperative 51 VUR 51 carotid artery ultrasound 51 upper gastrointestinal bleeding 51 endoscopic ultrasonography 51 Logistic regression analysis 51 rectal exam 51 HBeAg seroconversion 51 thrombus aspiration 51 thromboembolic 51 BRCA carriers 51 chest radiograph 51 Zevalin consolidation 51 VAD implantation 51 LQTS 51 low expressors 51 Bonferroni correction 51 positron emission 51 NP CRNs 51 seminoma 51 radiographic examinations 51 cardiac perfusion 51 nonmelanoma skin cancer 51 MR spectroscopy 51 shock wave lithotripsy 51 prostate 51 computed tomography CT angiography 51 hsCRP 51 cancerous lesions 51 tPSA 51 APTIVUS r 51 Digital Mammographic Imaging 51 AF ablation procedures 51 colonoscopies 51 DES implantation 51 antiviral therapy 51 sCJD 51 thymectomy 51 thromboembolic events 51 prostatic 51 coronary interventions 51 conditional logistic regression 51 CT angiography CTA 51 diagnostic catheterization 51 breast conserving lumpectomy 51 cryptogenic stroke 51 aminotransferases 51 intensive statin therapy 51 spirometric 51 yearly mammograms 51 stereotactic radiotherapy 51 ablation procedure 51 preoperative radiotherapy 51 benign lesion 51 computed tomographic 51 noncancer 51 posttransplant 51 stable angina 51 antiplatelet therapy 51 comorbidity 51 situ LCIS 51 FFR guided treatment 51 Garzotto 51 lymphocytosis 51 allogeneic transplants 51 precancerous tumors 51 pancreatic adenocarcinoma 51 liver metastasis 51 perioperatively 51 K ras mutations 51 microsatellite instability 51 Inhibin B 51 randomized multicenter trial 51 prognostic significance 51 Androgen Deprivation Therapy 51 imatinib therapy 51 obstructive coronary artery 51 coronary stenting 51 response pCR 51 serum cortisol 51 lymph node 51 adenomatous 51 aneurysm rupture 51 ProstaScint 51 enucleation 51 vasectomy reversal

Back to home page